Riber's stock ran 153% on quantum; its revenue runs on one export license

The French MBE toolmaker swung back to profit on a 71% surge in services and parts, then made its whole 2026 outlook conditional on an export license toward Asia. More than €8 million of orders exist and cannot be booked.

In this storyNVO
Vincent JiangVincent Jiang · 2 min read
Share
A technician in a white lab coat works on a Riber SIVA 21 molecular beam epitaxy system, a large steel vacuum chamber ringed with pipes, cables and flanges.
A technician at work on a Riber SIVA 21 molecular beam epitaxy system. Riber's machines deposit semiconductor material near atom by atom and sell for more than €1 million each.

Two machines bound for China sat in final test

On a residential street in Bezons, west of Paris, a grey warehouse holds 120 people who build machines that lay down semiconductor materials almost atom by atom. Twelve machines a year leave its six assembly slots, each priced above €1 million, each ordered 12 to 15 months ahead. When a French business-TV crew walked the floor this week, two machines in final test were bound for China. 1

A 153% rally meets a conditional forecast

Riber's stock closed Friday at €8.87, down 5.03% on the day and up 153.43% since January, a repricing built on photonics, AI and quantum hope. 3 A day earlier, the company had guided 2026 revenue to a level comparable with 2025's €40.3 million, subject to one condition: obtaining an export license toward Asia. 25 The shares fell 2.5% on results day and another 5% on Friday. 43

Demand is present; permission is not

The order book shows demand is not the constraint. Export restrictions kept more than €8 million of Asian orders from converting into the backlog at 30 June; systems orders fell 27% to €16.5 million while services orders rose 98% to €10.3 million. 26 Asia was 40.4% of revenue in the latest disclosed geographic split. 3 The customers exist; the paperwork does not.

Orders stuck at the border equal nearly half of what systems booked all half

€0M€5M€10M€15M€20MSystems orders booked€16.5MServices orders booked€10.3MAsian orders blocked>€8M
Data
Value
Systems orders booked€16.5M
Services orders booked€10.3M
Asian orders blocked>€8M
Riber order intake for the six months to 30 June 2026 versus Asian orders held back by export restrictions, € millions; company-reported figures. Sources: Riber H1 2026 results release [2]; Compound Semiconductor [6].2,6

Services and parts carried the half

The half itself was carried by the parts counter. Revenue rose 19% to €12.7 million and net income swung to €0.2 million from a €0.8 million loss, on services and accessories up 71% to €5.1 million while machine revenue slipped 1%. 2

Services and parts grew 71% while machine revenue stood still

  • H1 2025
  • H1 2026
-€2€0€2€4€6€8Machine revenue€7.7€7.8-1.3%Services and parts revenue€3.0€5.1+70%Net income-€0.8€0.2
Data
H1 2025H1 2026Change
Machine revenue€7.8€7.7-1.3%
Services and parts revenue€3.0€5.1+70.0%
Net income-€0.8€0.2—
Riber first-half results, € millions, six months to 30 June, 2025 vs 2026; company-reported figures. Source: Riber H1 2026 results release [2].2

The bull case lives in ROSIE

The bull case is real and it is ROSIE. A second platform shipped in July to a major US quantum computing player, and first samples from the work with the Novo Nordisk Foundation's quantum computing programme are due in the fourth quarter. 2 Customer of more than twenty years 3SP Technologies ordered another production platform for 2027 delivery. 7 Riber has drawn €6 million of bank debt to build ROSIE II, flipping net cash to minus €1.2 million. 2 The lone covering analyst keeps a €10 target and calls ROSIE progress the determinant. 4

One signature decides the year

What moves 2026 revenue is not a purchase order but a signature in a licensing office. Annual revenue lands 3 February 2027. 2

How this brief was made

Become a contributor

Reporting on the business of AI and want it read? We take pitches from outside contributors who bring primary sources and a number worth arguing about.

Share

Deepdive

AI-generated from this story and its cited sources. Not investment advice.

Reader comments

0 comments

    Sign up

    Get your curated digest

    After email confirmation, you will receive a daily digest of the most relevant news that matter to your portfolio